Loading…
Dr Lalchandani Labs (BSE 541299)₹6.47−2.12%Healthcare Service Provider
Dr Lalchandani Labs is compared with the 10 closest in size in Healthcare Service Provider (37 companies in the industry). It has a P/E of 107.8 against a peer median of 22.4, and ROCE of 0.8% against a peer median of 0.8%, and latest-quarter sales growth of −8.6% against a peer median of 24.1%. By market cap it is #9 of 11 in this set.
As of · Peer set: 10 closest in size in Healthcare Service Provider
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Transgene Biotek | 19 | — | −2.4 | −17.9 | 2.04 | 0.0 | 0 | −2 | 25.0 | — | vs BSE 541299 |
| Nidan Laboratories and Healthcare | 19 | 12.4 | 6.0 | 2.5 | 0.16 | 0.0 | 26 | 2 | −11.3 | −91.0 | vs BSE 541299 |
| Looks Health Services | 13 | — | 0.2 | 0.1 | 0.00 | 0.0 | 0 | 0 | 62.5 | — | vs BSE 541299 |
| Dolphin Medical Services | 11 | 711.0 | 0.6 | 0.4 | 0.09 | 0.0 | 1 | 0 | 38.5 | — | vs BSE 541299 |
| Family Care Hospitals | 11 | — | −25.6 | −38.4 | 0.55 | 0.0 | 0 | −9 | 300.0 | — | vs BSE 541299 |
| Dhanvantri Jeevan Rekha | 9 | 22.4 | 3.9 | 3.9 | 0.00 | 0.0 | 26 | 0 | 24.1 | 675.0 | vs BSE 541299 |
| Boston Commerce | 8 | — | 0.1 | −10.3 | 0.18 | 0.0 | 0 | −1 | −100.0 | — | vs BSE 541299 |
| Clinitech Laboratory | 7 | 16.4 | 7.2 | 4.7 | 0.06 | 0.0 | 9 | 0 | 6.0 | −27.8 | vs BSE 541299 |
| Dr Lalchandani Labs | 6 | 107.8 | 0.8 | 0.5 | 0.15 | 0.0 | 4 | 0 | −8.6 | −146.2 | — |
| Ashram Online.com | 5 | — | 0.8 | −1.2 | 0.32 | 0.0 | 0 | −0 | 25.0 | — | vs BSE 541299 |
| Gian Lifecare | 4 | — | 2.4 | −0.2 | 0.31 | 0.0 | 6 | −0 | −29.7 | −73.5 | vs BSE 541299 |
| Peer median | 9 | 22.4 | 0.8 | 0.1 | 0.16 | 0.0 | 1 | 0 | 24.1 | −73.5 |
Listed companies closest to Dr Lalchandani Labs in Healthcare Service Provider include Transgene Biotek, Nidan Laboratories and Healthcare, Looks Health Services, Dolphin Medical Services, Family Care Hospitals, Dhanvantri Jeevan Rekha, Boston Commerce, Clinitech Laboratory.
Transgene Biotek, with a market cap of ₹19.10 Cr.
Dr Lalchandani Labs trades at a P/E of 107.8; the median of its peer set is 22.4. A P/E above or below the median is a description, not a judgement on value.
Dr Lalchandani Labs' return on capital employed is 0.8%, above the peer median of 0.8%.